跳至主要内容
临床试验/NCT00500838
NCT00500838已完成不适用

CRT-D Based Impedance Monitoring Feasibility Study

Abbott Medical Devices8 个研究点 分布在 1 个国家目标入组 75 人开始时间: 2007年7月最近更新:
适应症
干预措施

试验速览

阶段
不适用
状态
已完成
入组人数
75
试验地点
8
主要终点
To assess the use of the impedance feature in conjunction with other functions of the CRT-D device

研究概览

简要总结

The intent of this feasibility study is to collect and analyze intra-thoracic impedance measurements from a CRT-D device in a heart failure population.

详细描述

This is a multi-center feasibility study intended to collect information on changes in intra-thoracic impedance measurements from CRT-D devices. In order to obtain an intra-thoracic impedance measurement, the device delivers a subthreshold impulse that measures the resistance between two electrodes.

At the programmed interval, measurements will be obtained between six different lead configurations.

研究设计

研究类型
Interventional
分配方式
Na
干预模型
Single Group
主要目的
Device Feasibility
盲法
None

入排标准

年龄范围
18 Years 至 —(Adult, Older Adult)
性别
All
接受健康志愿者

入选标准

  • Eligible patients will meet all of the following:
  • Have an approved indication per American College of Cardiology/American Heart Association/Heart Rhythm Society guidelines for implantation of a Cardiac Resynchronization Therapy Defibrillator (CRT-D) or have a previously implanted St. Jude Medical (SJM) CRT-D system capable of enabling the diagnostic impedance monitoring feature with implant occurring within the last 14 days
  • Have had at least one hospitalization, emergency department visit, or clinic visit within the past 12 months for treatment of decompensated heart failure requiring intravenous diuretics, intravenous inotropes, Natrecor (Nesiritide) therapy, or an increase in an oral diuretic of ≥100% over a 24 hour period
  • Have the ability to maintain a patient diary for recording daily weights, symptoms related to heart failure, changes in diuretic therapy, and any unscheduled clinic or hospital visits
  • Have the ability to provide informed consent for study participation and be willing and able to comply with the prescribed follow-up tests and schedule of evaluation

排除标准

  • Patients will be excluded if they meet any of the following:
  • Be less than 18 years of age
  • Have had a recent myocardial infarction, unstable angina or cardiac revascularization within 40 days of enrollment
  • Have had a recent Cerebrovascular Accident or Transient Ischemic Attack within three months of enrollment
  • Have a contraindication for an emergency thoracotomy
  • Have an indication that requires programming device in atrial pacing mode
  • Have permanent (chronic) atrial fibrillation
  • Have a capped or inactive right atrial or right ventricular pacing/defibrillator lead
  • Have a hypersensitivity to a single 1.0mg dose of dexamethasone sodium phosphate or short term contact with heparin
  • Be pregnant or planning a pregnancy in the next 6-months
  • Be currently participating in a clinical investigation that includes an active treatment arm
  • Have a life expectancy of less than six months due to any condition

研究组 & 干预措施

1

Experimental

Transthoracic impedance device implanted.

干预措施: Transthoracic Impedance (Device)

结局指标

主要结局

To assess the use of the impedance feature in conjunction with other functions of the CRT-D device

时间窗: 6 months

次要结局

未报告次要终点

研究者

申办方类型
Industry
责任方
Sponsor

研究点 (8)

Loading locations...

相似试验